HER2 overexpression is related to an increased risk of CNS metastasis, and the proportion of cases with CNS metastasis in HER2-positive BC patients ranges from 30–55%(Aleanizy et al. 2020; Zimmer et al. 2020). The gene discussed is ERBB2; the disease is breast cancer.